Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs
about
Management of Multiple Sclerosis in the Breastfeeding MotherUse of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)Pregnancy related issues in inflammatory bowel disease: evidence base and patients' perspectiveTreatment of pregnant women with a diagnosis of inflammatory bowel diseaseManaging inflammatory bowel disease in pregnancy: current perspectivesHow I treat my inflammatory bowel disease-patients with thiopurines?Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.Utility of maternal 6-thioguanine nucleotide levels in predicting neonatal pancytopenia.Pregnancy and breastfeeding in patients with Crohn's disease.Management of distal ulcerative colitis: frequently asked questions analysis.Is breastfeeding safe with azathioprine?Management of the pregnant IBD patient.Management of early aggressive rheumatoid arthritis during pregnancy and lactation.From conception to delivery: managing the pregnant inflammatory bowel disease patient.The Asia-Pacific consensus on ulcerative colitis.Inflammatory bowel disease and pregnancy: an update.Thiopurine therapy in inflammatory bowel disease.European evidenced-based consensus on reproduction in inflammatory bowel disease.Safety considerations: breastfeeding after transplant.IBD medications during pregnancy and lactation.Vaccinating the inflammatory bowel disease patient.Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation.A practical guide to the use of thiopurines in oral medicine.Management of Eosinophilic Esophagitis During Pregnancy.Managing IBD Therapies in Pregnancy.Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy.Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding.Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease.
P2860
Q26766337-6D85CC33-5C76-4EF0-AD94-9808985598D5Q26996946-B15344ED-BCF9-4D6C-9A62-09D0ED96809BQ27004038-EB30F5CF-E460-4869-953E-1BE0779AF2A3Q28067821-05DAEB92-C657-456A-AFAF-F630E5E5EE1BQ28068318-586A1C71-467F-42F8-8A54-6A463B0ED9DBQ28076561-93CAB3D0-5D9F-4819-B5E4-23D089A04262Q33819478-53E712DE-D3EE-40D8-9126-8E4DE7CF716EQ34152778-CC3F7216-75C5-4883-865D-77F1776346F4Q34244877-1E35DDA9-1DC8-4819-93D8-BF159A8E01B2Q36975357-B6EBE8B5-22DF-4D6F-A932-EDAD9B8EA890Q37073424-70FD5517-6BBD-4209-96AE-AAA6F7D0DB5BQ37091094-7E0A6BDC-0BEF-4F1F-AD5F-DD48E11C51F4Q37185910-2374100A-4E03-411D-B077-DFCE2F42B014Q37216502-B41247CE-213D-4276-BE83-07E87607DE6DQ37510901-6FD244A6-1F6B-4EDD-8BBF-046217C1D0D7Q37682503-CD577282-1907-4173-B577-70EF3FB813A8Q37725083-DCE43D6D-0912-4DBE-90A8-829CE68C4564Q37769252-0BEDC757-8ABB-4E44-803D-B89E0249754AQ37798819-6BC78654-E5FF-4604-80EC-26A986E8EDB9Q37814564-0B481B34-DDB2-487E-988C-B4FE5141F332Q38115646-4A171CE5-2162-4872-A37F-35239CBD23B9Q38125114-5D29478B-CB48-4F92-9DFF-E4E14365451FQ38243693-F23596A9-99BF-4000-86F9-476FE027D5E1Q38246990-1EC54EA5-02EB-4790-A18D-38963F43D651Q38295916-3C5EC69C-1A10-493B-B795-A1F852D67AC5Q38738250-B086491C-ABCB-4C52-BF9F-1B5AD86E1309Q38970533-B625B4AE-DD1C-4E77-93D7-3CC62C4629E3Q41601749-6B362C31-F09E-47F4-90E1-C3BC4CAAD607Q45116620-C89E47FC-AAF3-4D93-A1F9-B1A4AF04C033Q46166151-E2D14BA8-6D8A-4A47-86E1-A9A1FA7CE4B4Q48019757-8F0182B0-C4C3-43F1-9EED-142A4EB68EB7
P2860
Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Exposure to thiopurine drugs t ...... rations in mother-infant pairs
@ast
Exposure to thiopurine drugs t ...... rations in mother-infant pairs
@en
Exposure to thiopurine drugs t ...... rations in mother-infant pairs
@nl
type
label
Exposure to thiopurine drugs t ...... rations in mother-infant pairs
@ast
Exposure to thiopurine drugs t ...... rations in mother-infant pairs
@en
Exposure to thiopurine drugs t ...... rations in mother-infant pairs
@nl
prefLabel
Exposure to thiopurine drugs t ...... rations in mother-infant pairs
@ast
Exposure to thiopurine drugs t ...... rations in mother-infant pairs
@en
Exposure to thiopurine drugs t ...... rations in mother-infant pairs
@nl
P2093
P2860
P3181
P1476
Exposure to thiopurine drugs t ...... rations in mother-infant pairs
@en
P2093
Evan J Begg
Murray L Barclay
Rebecca L Roberts
Richard B Gearry
Sharon J Gardiner
P2860
P3181
P356
10.1111/J.1365-2125.2006.02639.X
P407
P577
2006-10-01T00:00:00Z